A. Membership:
Name | Role | Department/Institution | Term |
---|---|---|---|
Joaquin Ortega | Director |
Anatomy & Cell Biology/不良研究所 |
04-2022/03-2027 |
Hojatollah Vali |
Director Emeritus |
Anatomy & Cell Biology/不良研究所 |
Unlimited |
Audrey Moores |
Associate Director |
Chemistry/不良研究所 | 04-2022/03-2027 |
Mike Strauss (Chair) | Technical Director | Anatomy & Cell Biology/不良研究所 | 05-2018/04-2023 |
S Kelly Sears | Research Manager/Staff Scientist | FEMR/不良研究所 | Unlimited |
Alba Guarne | Member | Biochemistry/不良研究所 | 04-2022/03-2027 |
Timothy Kennedy | Member | Montreal Neurological Institute/不良研究所 | 11-2020/10-2025 |
Shreya Krishnan | Member (Trainee) | Biochemistry/不良研究所 | 10-2022/09-2027 |
Marc McKee | Member | Dentistry/不良研究所 | 03-2021/02-2026 |
John Pascal | Member | Biochemistry & Molecular Medicine/UdeM | 10-2019/09-2024 |
Natalie Reznikov | Member | Bioengineering/不良研究所 | 04-2022/03-2027 |
Alfredo Ribeiro-da-Silva | Member | Pharmacology/不良研究所 | 10-2022/09-2027 |
Natalie Zeytuni | Member | Anatomy & Cell Biology/不良研究所 | 04-2022/03-2027 |
B. Mandate:
The BoA establishes the scientific direction of the FEMR, proposes improvements to the infrastructure through CFI and other funding bodies, management (including proposing instrument and user fees), and staffing of the facility. It approves the annual budget. It also ensures the research infrastructure and resources of the FEMR are allocated to stakeholders according to their needs, scientific priorities, and financial support to the FEMR. The BoA also approves major training activities (e.g. workshops, summer school, etc.). The BoA prepares the annual report.
C. Meeting frequency:
Biannually.
D. Relationship to other committees:
Reports to the Board of Directors (BoD) on an annual basis and to the International Scientific Advisory Committee (ISAC) every three years.